92 related articles for article (PubMed ID: 31859394)
1. A point mutation c.473A > G of ITGB3 is responsible for the formation of the Wo
Holzwarth ST; Strobel J; Cooper N; Leyh J; Bayat B; Bein G; Zingsem J; Sachs UJ
Transfusion; 2020 Jan; 60(1):E5-E6. PubMed ID: 31859394
[No Abstract] [Full Text] [Related]
2. A new low-frequency alloantigen (Kha(b) ) located on platelet glycoprotein IIIa as a cause of maternal sensitization leading to neonatal alloimmune thrombocytopenia.
Sullivan MJ; Peterson J; McFarland JG; Bougie D; Aster RH; Curtis BR
Transfusion; 2015 Jun; 55(6 Pt 2):1584-5. PubMed ID: 25494608
[No Abstract] [Full Text] [Related]
3. Severe neonatal alloimmune thrombocytopenia caused by maternal sensitization against a new low-frequency alloantigen (Dom
Sullivan MJ; Kuhlmann R; Peterson JA; Curtis BR
Transfusion; 2017 Jul; 57(7):1847-1848. PubMed ID: 28518345
[No Abstract] [Full Text] [Related]
4. Neonatal alloimmune thrombocytopenia due to a new alloantigen Bl(a) defined by an Asp458Gly substitution in GPIIIa.
Poles A; Lucas G; Green F; Walser P; Davey S; Ridgwell K; Wylie P
Transfusion; 2019 Jan; 59(1):396-404. PubMed ID: 30488955
[TBL] [Abstract][Full Text] [Related]
5. A new platelet alloantigen (Efs
Bertrand G; Danger Y; Croisille L; Le Toriellec E; Verite F; Renac V; Bierling P
Transfusion; 2019 Jul; 59(7):2463-2464. PubMed ID: 30942487
[No Abstract] [Full Text] [Related]
6. The new platelet alloantigen Cab a: a single point mutation Gln 716 His on the alpha 2 integrin.
Bertrand G; Jallu V; Saillant D; Kervran D; Martageix C; Kaplan C
Transfusion; 2009 Oct; 49(10):2076-83. PubMed ID: 19500323
[TBL] [Abstract][Full Text] [Related]
7. A nait-associated and previously unreported mutation in the ITGB3 gene with a low frequency in the local population.
Norrenbrock S; Müller TH; Mayer C; Doescher A
Transfus Med; 2021 Aug; 31(4):286-291. PubMed ID: 33724573
[TBL] [Abstract][Full Text] [Related]
8. HPA-1a(-), 5b(-) platelets for use in neonatal alloimmune thrombocytopenia--from 'Cinderella' product to standard component.
Lucas GF; Bendukidize N
Transfus Med; 2014 Apr; 24(2):127-9. PubMed ID: 24684573
[No Abstract] [Full Text] [Related]
9. Treatment of fetomaternal neonatal alloimmune thrombocytopenia with random platelets.
Bakchoul T; Sachs UJ; Wittekindt B; Sclösser R; Bein G; Santoso S
Pediatr Blood Cancer; 2008 Jun; 50(6):1293-4. PubMed ID: 18293389
[No Abstract] [Full Text] [Related]
10. Toward a prophylaxis against fetal and neonatal alloimmune thrombocytopenia: induction of antibody-mediated immune suppression and prevention of severe clinical complications in a murine model.
Tiller H; Killie MK; Chen P; Eksteen M; Husebekk A; Skogen B; Kjeldsen-Kragh J; Ni H
Transfusion; 2012 Jul; 52(7):1446-57. PubMed ID: 22251227
[TBL] [Abstract][Full Text] [Related]
11. Predicting risk severity and response of fetal neonatal alloimmune thrombocytopenia.
Salomon O; Rosenberg N
Br J Haematol; 2013 Aug; 162(3):304-12. PubMed ID: 23672281
[TBL] [Abstract][Full Text] [Related]
12. MYH9-macrothrombocytopenia caused by a novel variant (E1421K) initially presenting as apparent neonatal alloimmune thrombocytopenia.
Samelson-Jones BJ; Kramer PM; Chicka M; Gunning WT; Lambert MP
Pediatr Blood Cancer; 2018 Apr; 65(4):. PubMed ID: 29286575
[TBL] [Abstract][Full Text] [Related]
13. Preimplantation genetic diagnosis for fetal neonatal alloimmune thrombocytopenia due to antihuman platelet antigen maternal antibodies.
Altarescu G; Eldar-Geva T; Grisaru-Granovsky S; Bonstein L; Miskin H; Varshver I; Margalioth EJ; Levy-Lahad E; Renbaum P
Obstet Gynecol; 2012 Feb; 119(2 Pt 1):338-43. PubMed ID: 22270286
[TBL] [Abstract][Full Text] [Related]
14. Do we know when to treat neonatal thrombocytopaenia?
Venkatesh V; Curley AE; Clarke P; Watts T; Stanworth SJ
Arch Dis Child Fetal Neonatal Ed; 2013 Sep; 98(5):F380-2. PubMed ID: 23531628
[No Abstract] [Full Text] [Related]
15. The αIIb p.Leu841Met (Cab3(a+) ) polymorphism results in a new human platelet alloantigen involved in neonatal alloimmune thrombocytopenia.
Jallu V; Bertrand G; Bianchi F; Chenet C; Poulain P; Kaplan C
Transfusion; 2013 Mar; 53(3):554-63. PubMed ID: 22738334
[TBL] [Abstract][Full Text] [Related]
16. A V740L mutation in glycoprotein IIb defines a novel epitope (War) associated with fetomaternal alloimmune thrombocytopenia.
Poles A; Woźniak MJ; Walser P; Ridgwell K; Fitzgerald J; Green A; Gilmore R; Lucas G
Transfusion; 2013 Sep; 53(9):1965-73. PubMed ID: 23305224
[TBL] [Abstract][Full Text] [Related]
17. A single-nucleotide polymorphism in the human ITGB3 gene is associated with the platelet-specific alloantigen Va (HPA-17bw) involved in fetal maternal alloimmune thrombocytopenia.
Stafford P; Garner SF; Rankin A; Kekomaki R; Watkins NA; Ouwehand WH
Transfusion; 2008 Jul; 48(7):1432-8. PubMed ID: 18484951
[TBL] [Abstract][Full Text] [Related]
18. A third allele of the HPA-5 (Br) platelet alloantigen system identified in investigating a case of neonatal thrombocytopenia.
Peterson JA; Gitter ML; Pietz B; Bellissimo D; Curtis B; Aster R
Transfusion; 2010 Aug; 50(8):1855-6. PubMed ID: 20883258
[No Abstract] [Full Text] [Related]
19. A new Ser472Asn (Cab2(a+)) polymorphism localized within the αIIb "thigh" domain is involved in neonatal thrombocytopenia.
Jallu V; Dusseaux M; Kaplan C
Transfusion; 2011 Feb; 51(2):393-400. PubMed ID: 20723174
[TBL] [Abstract][Full Text] [Related]
20. Severe neonatal alloimmune thrombocytopaenia with anaemia.
Novelli S; Canals C; Nogués N; Julià MR; Gracia M; Vinyets I; Muñiz-Diaz E
Transfus Med; 2010 Apr; 20(2):125-6. PubMed ID: 19874559
[No Abstract] [Full Text] [Related]
[Next] [New Search]
